prognosis but is often temporary and resolves after treatment completion in esophageal
cancer. How lymphocyte recovery contributes to prognosis is unknown. Methods We
reviewed 755 patients with stage I-III esophageal carcinoma who received concurrent
chemoradiation therapy (CRT) with or without surgery in 2004–2015. Complete blood
counts were obtained before, during, and at first follow-up after CRT. Lymphopenia was …